NCBI Logo
GEO Logo
   NCBI > GEO > Accession DisplayHelp Not logged in | LoginHelp
GEO help: Mouse over screen elements for information.
          Go
Sample GSM3941270 Query DataSets for GSM3941270
Status Public on Mar 10, 2020
Title A0P-520232-T-RNA [S104]
Sample type SRA
 
Source name Allograft_0Gy_PD1_Tumor
Organism Mus musculus
Characteristics strain background: 129/SvJae
replicate group: Allograft_0Gy_PD1_Tumor_RNA
barcode: CTGAAGCT+GTACTGAC
tumor type: Allograft
radiation dose: 0Gy
treatment: anti-PD1
Treatment protocol Tumors were treated when volume reached ~150 mm3 and harvested 3 days later. Mice received 200 ug IP of either muDX400 (Merck, murine anti-PD-1) or isotype control followed immediately by 0 or 20 Gy radiation. For mice receiving radiation, the tumor-bearing hind limb of the mice was irradiated with 20 Gy using the X-RAD 225Cx small animal image-guided irradiator (Precision X-Ray). The irradiation field included the whole left hind limb and was defined using fluoroscopy with 40 kVp, 2.5 mA X-rays using a 2 mm Al filter. Irradiations were performed using parallel-opposed anterior and posterior fields with an average dose rate of 300 cGy/min prescribed to midplane with 225 kVp, 13 mA X-rays using a 0.3 mm Cu filter.
Growth protocol Primary p53/MCA sarcomas were generated in mice between 6-10 weeks old by intramuscular Adeno-Cre injection into the gastrocnemius of p53FL/FL mice, followed by injection of 300 µg MCA (Sigma-Aldrich) resuspended in sesame oil (SigmaAldrich) at 6 µg/µl. Allograft p53/MCA sarcomas were generated by injecting 50,000 cells resuspended in 100 uL DMEM (Gibco) and Corning matrigel from cell line 402230 into the gastrocnemius muscle of syngeneic mice.
Extracted molecule total RNA
Extraction protocol Tumor specimens and matched liver control were harvested and stored in RNALater at -80° until all samples were collected. DNA and RNA extractions from each sample were performed using AllPrep DNA/RNA Mini Kit (Qiagen). Extracted total RNA quality and concentration was assessed on a 2100 Bioanalyzer (Agilent Technologies) and Qubit 2.0 (ThermoFisher Scientific), respectively. Only extracts with RNA Integrity Number (RIN) greater than 7 were processed for sequencing. DNA extraction was followed by RNAse treatment (Qiagen). Genomic DNA samples were quantified using fluorometric quantitation on the Qubit 2.0 (ThermoFisher Scientific). For each sample, 200 ng of DNA was sheared using focused-ultrasonicators (Covaris) to generate DNA fragments of about 300 bp in length.
RNA-seq libraries were prepared using the commercially available KAPA Stranded mRNA-Seq Kit (Roche) following the manufacturer’s protocol. In brief, mRNA transcripts were first captured using magnetic oligo-dT beads, fragmented using heat and magnesium, and reverse transcribed using random priming. During the 2nd strand synthesis, the cDNA:RNA hybrid was converted into to double-stranded cDNA (dscDNA) and dUTP incorporated into the 2nd cDNA strand, effectively marking the second strand. Illumina sequencing adapters were then ligated to the dscDNA fragments and amplified to produce the final RNA-seq library. The strand marked with dUTP was not amplified, allowing strand-specificity sequencing.
Libraries were indexed using a dual indexing approach allowing for multiple libraries to be pooled and sequenced on the same sequencing Illumina sequencing flow cell.
 
Library strategy RNA-Seq
Library source transcriptomic
Library selection cDNA
Instrument model Illumina NovaSeq 6000
 
Description 4654-S104_S8_L001
Data processing Base-calling was done on the instrument using RTA v3.3.3. 
Demultiplexing was done using bcl2fatq v2.20.0.422
Sequenced reads were trimmed for adaptor sequence and low-quality sequence using Trimmomatic v0.36
Reads were mapped to mouse mm10 genome using STAR v5.5.4b and quantified to features using HT-Seq built in the STAR aligner.
Genome_build: mm10
Supplementary_files_format_and_content: csv file with read counts per gene
 
Submission date Jul 15, 2019
Last update date Apr 17, 2020
Contact name David Kirsch
E-mail(s) david.kirsch@duke.edu
Organization name Duke University
Street address PO Box 96100
City Durham
State/province NC
ZIP/Postal code 27710
Country USA
 
Platform ID GPL24247
Series (1)
GSE134273 A single cell atlas of tumor resistance to PD-1 blockade and radiotherapy: Bulk Tumor RNA Sequencing
Relations
Alternative to GSM4484091
BioSample SAMN12275335
SRA SRX6442199

Supplementary data files not provided
SRA Run SelectorHelp
Raw data are available in SRA
Processed data are available on Series record

| NLM | NIH | GEO Help | Disclaimer | Accessibility |
NCBI Home NCBI Search NCBI SiteMap